Guru Ownership Trend
Guru Analysis for Design Therapeutics, Inc. (DSGN)
Design Therapeutics, Inc. (DSGN), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $43.15 M.
Top institutional holders include Steven Cohen and Renaissance Technologies (RenTech).
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $26.77 M net outflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 89.1%. Conversely, Steven Cohen reduced exposure by 49.3%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Design Therapeutics, Inc. (DSGN)
Major holders include Steven Cohen ($28.97 M), Renaissance Technologies (RenTech) ($4.34 M), Cliff Asness ($276,184). According to the latest reported data, 3 tracked investment managers collectively hold approximately 3.16 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $26.77 M, with 2 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited DSGN. The total reported sell value was $28.19 M.
Yes, 0 managers opened new positions in DSGN, and 2 increased their existing holdings. The total reported buy value was $1.42 M.